OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Michael P. Ludwig, Matthew D. Galbraith, Neetha Paul Eduthan, et al.
Cancer Research (2023) Vol. 83, Iss. 15, pp. 2543-2556
Open Access | Times Cited: 8
Michael P. Ludwig, Matthew D. Galbraith, Neetha Paul Eduthan, et al.
Cancer Research (2023) Vol. 83, Iss. 15, pp. 2543-2556
Open Access | Times Cited: 8
Showing 8 citing articles:
ATF4 in cellular stress, ferroptosis, and cancer
Hu Tang, Rui Kang, Jiao Liu, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 4, pp. 1025-1041
Closed Access | Times Cited: 32
Hu Tang, Rui Kang, Jiao Liu, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 4, pp. 1025-1041
Closed Access | Times Cited: 32
Preclinical models of soft tissue sarcomas – generation and applications to enhance translational research
Sandro Pasquali, David S. Moura, Mary K. Danks, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104621-104621
Open Access | Times Cited: 1
Sandro Pasquali, David S. Moura, Mary K. Danks, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104621-104621
Open Access | Times Cited: 1
Harnessing p53 for targeted cancer therapy: new advances and future directions
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access | Times Cited: 1
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access | Times Cited: 1
MDM2 inhibitor induces apoptosis in colon cancer cells through activation of the CHOP-DR5 pathway, independent of p53 phenotype
Manman Lu, Yingli Ren, Sijia Feng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Manman Lu, Yingli Ren, Sijia Feng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Effects of Deregulated Ribosomal Biogenesis in Cancer
Yiwei Lu, Shizhuo Wang, Yisheng Jiao
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1593-1593
Open Access | Times Cited: 9
Yiwei Lu, Shizhuo Wang, Yisheng Jiao
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1593-1593
Open Access | Times Cited: 9
Novel pharmacotherapies for the treatment of liposarcoma: a comprehensive update
Teresa Y. Lee, Margaret von Mehren
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 17, pp. 2293-2306
Closed Access | Times Cited: 1
Teresa Y. Lee, Margaret von Mehren
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 17, pp. 2293-2306
Closed Access | Times Cited: 1
Deciphering the prognostic and therapeutic significance of BAG1 and BAG2 for predicting distinct survival outcome and effects on liposarcoma
Yingying Lian, Jiahao Chen, Jiayang Han, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Yingying Lian, Jiahao Chen, Jiayang Han, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
All-stage targeted nanodiscs for glioma treatment by inducing cuproptosis and apoptosis of cancer cells and cancer stem cells
Yuan Ding, Ruohan Chen, Jianfen Zhou, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 20, Iss. 2, pp. 101010-101010
Open Access
Yuan Ding, Ruohan Chen, Jianfen Zhou, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 20, Iss. 2, pp. 101010-101010
Open Access
